Lamotrigine efficacy, safety, and tolerability for women of childbearing age with bipolar I disorder: Meta-analysis from four randomized, placebo-controlled maintenance studies-Reference-Cited by-同舟云学术

Lamotrigine efficacy, safety, and tolerability for women of childbearing age with bipolar I disorder: Meta-analysis from four randomized, placebo-controlled maintenance studies

Published:2024-01 Issue: Volume:78 Page:81-92
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Vieta Eduard^ORCID,Ghorpade Sanman,Biswas Arunangshu,Sarkar Angshuman,Phansalkar Abhay^ORCID,Cooper James^ORCID

Funder

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference47 articles.

1. Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network;Altshuler;Am. J. Psychiatry,2010

2. Bipolar depression: a major unsolved challenge;Baldessarini;Int. J. Bipolar Disord.,2020

3. Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review;Besag;Ther. Adv. Psychopharmacol.,2021

4. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder;Bowden;Arch. Gen. Psychiatry,2003

5. Early cognitive development in children born to women with epilepsy: a prospective report;Bromley;Epilepsia,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond One-Size-Fits-All: Personalized Medicine and Future Directions in Sex-Based Psychopharmacological Treatment;Future Pharmacology;2024-08-20

2. Measurement of lithium response in patients with bipolar disorder using the Retrospective Assessment of Response to Lithium Scale (Alda scale);Precision and Future Medicine;2024-06-30

3. Teratogenicity of valproate: Further reasons for action;European Neuropsychopharmacology;2024-03

4. Moving forward in bipolar disorder research;Spanish Journal of Psychiatry and Mental Health;2023-10